Weydandt, L.; Nel, I.; Kreklau, A.; Horn, L.-C.; Aktas, B.
Heterogeneity between Core Needle Biopsy and Synchronous Axillary Lymph Node Metastases in Early Breast Cancer Patients—A Comparison of HER2, Estrogen and Progesterone Receptor Expression Profiles during Primary Treatment Regime. Cancers 2022, 14, 1863.
https://doi.org/10.3390/cancers14081863
AMA Style
Weydandt L, Nel I, Kreklau A, Horn L-C, Aktas B.
Heterogeneity between Core Needle Biopsy and Synchronous Axillary Lymph Node Metastases in Early Breast Cancer Patients—A Comparison of HER2, Estrogen and Progesterone Receptor Expression Profiles during Primary Treatment Regime. Cancers. 2022; 14(8):1863.
https://doi.org/10.3390/cancers14081863
Chicago/Turabian Style
Weydandt, Laura, Ivonne Nel, Anne Kreklau, Lars-Christian Horn, and Bahriye Aktas.
2022. "Heterogeneity between Core Needle Biopsy and Synchronous Axillary Lymph Node Metastases in Early Breast Cancer Patients—A Comparison of HER2, Estrogen and Progesterone Receptor Expression Profiles during Primary Treatment Regime" Cancers 14, no. 8: 1863.
https://doi.org/10.3390/cancers14081863
APA Style
Weydandt, L., Nel, I., Kreklau, A., Horn, L. -C., & Aktas, B.
(2022). Heterogeneity between Core Needle Biopsy and Synchronous Axillary Lymph Node Metastases in Early Breast Cancer Patients—A Comparison of HER2, Estrogen and Progesterone Receptor Expression Profiles during Primary Treatment Regime. Cancers, 14(8), 1863.
https://doi.org/10.3390/cancers14081863
